Squarepoint Ops LLC Seres Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 44,747 shares of MCRB stock, worth $39,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,747

Holding current value

$39,377

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.48 $31,322 - $66,225	44,747 New	44,747 $42,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $106,020 - $245,100	114,000 New	114,000 $159,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $102,321 - $288,775	37,897 New	37,897 $130,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $121,986 - $171,168	-19,363 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $116,565 - $221,319	19,363 New	19,363 $161,000
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $78,394 - $324,490	-14,358 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $2.36 Million - $3.12 Million	-128,024 Reduced 89.92%	14,358 $342,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $11,832 - $19,376	670 Added 0.47%	142,382 $2.93 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $747,999 - $1.21 Million	32,172 Added 29.37%	141,712 $3.47 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $33,936 - $260,786	-9,074 Reduced 7.65%	109,540 $3.1 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $197,542 - $402,882	64,981 Added 121.16%	118,614 $565,000
Q1 2020 May 15, 2020	SELL	$2.64 - $3.82 $574,606 - $831,438	-217,654 Reduced 80.23%	53,633 $191,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $651,183 - $962,618	217,787 Added 407.08%	271,287 $936,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $122,515 - $222,560	53,500 New	53,500 $215,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $100,281 - $126,275	-13,681 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $94,535 - $130,653	13,681 New	13,681 $118,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$20.3 Million
3.73% of portfolio
Vanguard Group Inc Valley Forge, PA

6.06M
Shares

$5.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.55 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.39M
Shares

$1.22 Million
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

1.19M
Shares

$1.05 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $109M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account